On June 6th, LebNet Boston hosted an insightful event at MIT, focusing on AI/ML advancements in healthcare, challenges and opportunities in the healthcare value chain, and ongoing disruptions in biotech and health-tech.

The event featured a panel of experts including Ramy Arnaout, Jean-Claude Saghbini, Diana Ezzeddine, and Maya Said, moderated by Anthony Tayoun, and was attended by industry professionals and students.

The discussion covered several key topics: each panelist introduced themselves and shared recent developments in their fields, delved into the impact of AI/ML advancements on immunology and pathology post-COVID, and explored the use of AI/ML tools in oncology and drug discovery. The role of tech-enabled care delivery in complementing discovery-side advancements was highlighted, along with an explanation of value-based care and the role of AI in promoting it. Panelists shared predictions on significant changes and areas of stagnation in the healthcare industry over the next few years and provided valuable advice for biotech and health-tech startup founders. Additionally, they discussed the probabilistic nature of AI, its potential limitations in healthcare applications, and its intersection with pathology and various diagnostic areas.

Our gratitude goes to the panelists, the moderator, and the LebNet Boston leadership team for organizing this event, as well as to the community for joining us. Special thanks also to the Lebanese Club at MIT for hosting and E14 for sponsoring the event.

Another resounding success for the LebNet Boston community, leaving attendees eager for future events on cutting-edge topics!